Advertisement

N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

      Contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) is frequent and associated with long-term renal impairment and mortality. Early markers of CIN are needed to improve risk stratification. We aimed to assess whether N-terminal fragment of pro B-type natriuretic peptide (Nt-proBNP) could be associated with CIN. From the French regional RICO survey, all the consecutive patients who underwent primary PCI for STEMI, from January 1, 2001, to December 3, 2013, were included. Nt-proBNP circulating levels were assessed on admission. CIN was defined as an increase in serum creatinine >26.5 μmol/L or >50% within 48 to 72 hours after PCI (KDIGO criteria). Of the 1,243 patients included, CIN occurred in 130 patients (10.4%). Nt-proBNP levels were 5 times greater in patients who developed CIN than without CIN (1,275 [435 to 4,022] vs 247 [79 to 986] pg/mL, p <0.001). Hospital mortality rate was markedly higher in patients with CIN (6.9% vs 1.1%, p <0.001). Nt-proBNP levels were univariate predictors for CIN as were age, hypertension, diabetes, smoking, previous stroke, heart rate, impaired left ventricular ejection fraction C-reactive protein, history of renal failure, anemia, and estimated glomerular filtration rate <30 ml/min/1.73 m2 at baseline. Nt-proBNP levels remained strongly associated with the occurrence of CIN even after adjustment for risk factors, treatments, clinical and biological variables (odds ratio 1.99, 95% confidence interval 1.49 to 2.66). Net reclassification improvement was achieved by the addition of Nt-proBNP to the risk model (p = 0.003). In conclusion, from this large contemporary prospective study in nonselected population, our work suggests that Nt-proBNP levels at admission could help to identify patients at risk of CIN beyond traditional risk factors.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Marenzi G.
        • Lauri G.
        • Assanelli E.
        • Campodonico J.
        • De Metrio M.
        • Marana I.
        • Grazi M.
        • Veglia F.
        • Bartorelli A.L.
        Contrast-induced nephropathy in patients undergoing primary PCI for acute myocardial infarction.
        J Am Coll Cardiol. 2004; 44: 1780-1785
        • Goldberg A.
        • Hammerman H.
        • Petcherski S.
        • Zdorovyak A.
        • Yalonetsky S.
        • Kapeliovich M.
        • Agmon Y.
        • Markiewicz W.
        • Aronson D.
        Inhospital and 1-year mortality of patients who develop worsening renal function following acute ST-elevation myocardial infarction.
        Am Heart J. 2005; 150: 330-337
        • Solomon R.
        • Dauerman H.L.
        Contrast-induced acute kidney injury.
        Circulation. 2010; 122: 2451-2455
        • Rihal C.S.
        • Textor S.C.
        • Grill D.E.
        • Berger P.B.
        • Ting H.H.
        • Best P.J.
        • Singh M.
        • Bell M.R.
        • Barsness G.W.
        • Mathew V.
        • Garratt K.N.
        • Holmes D.R.
        Incidence and prognostic Importance of acute renal failure after percutaneous coronary intervention.
        Circulation. 2002; 105: 2259-2264
        • Wong P.C.
        • Li Z.
        • Guo J.
        • Zhang A.
        Pathophysiology of contrast-induced nephropathy.
        Int J Cardiol. 2012; 158: 186-192
        • Uyarel H.
        • Cam N.
        • Ergelen M.
        • Akkaya E.
        • Ayhan E.
        • Isik T.
        Contrast-induced nephropathy in patients undergoing primary PCI for acute myocardial infarction: incidence, a simple risk score, and prognosis.
        Arch Med Sci. 2009; 5: 550-558
        • Gassanov N.
        • Nia A.M.
        • Caglayan E.
        • Er F.
        Remote ischemic preconditioning and renoprotection: from myth to a novel therapeutic option?.
        J Am Soc Nephrol. 2014; 25: 216-224
        • Tang W.H.
        • Francis G.S.
        • Morrow D.A.
        • Newby L.K.
        • Cannon C.P.
        • Jesse R.L.
        • Storrow A.B.
        • Christenson R.H.
        • Apple F.S.
        • Ravkilde J.
        • Wu A.H.
        • National Academy of Clinical Biochemistry Laboratory Medicine
        National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure.
        Circulation. 2007; 116: 99-109
        • Jarai R.
        • Huber K.
        • Bogaerts K.
        • Droogne W.
        • Ezekowitz J.
        • Granger C.B.
        • Sinnaeve P.R.
        • Ross A.M.
        • Zeymer U.
        • Armstrong P.W.
        • Van de Werf F.J.
        • ASSENT IV-PCI investigators
        Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.
        Am Heart J. 2010; 159: 131-140
        • Jarai R.
        • Dangas G.
        • Huber K.
        • Xu K.
        • Brodie B.R.
        • Witzenbichler B.
        • Metzger D.C.
        • Radke P.W.
        • Yu J.
        • Claessen B.E.
        • Genereux P.
        • Mehran R.
        • Stone G.W.
        B-type natriuretic peptide and risk of contrast-induced acute kidney injury in acute ST-segment-elevation myocardial infarction: a substudy from the HORIZONS-AMI trial.
        Circ Cardiovasc Interv. 2012; 5: 813-820
        • Akgul O.
        • Uyarel H.
        • Pusuroglu H.
        • Isiksacan N.
        • Turen S.
        • Erturk M.
        • Surgit O.
        • Celik O.
        • Oner E.
        • Birant A.
        • Akturk I.F.
        • Uslu N.
        High BNP level as risk factor for acute kidney injury and predictor of all-cause mortality in STEMI patients.
        Herz. 2014; 39: 507-514
        • Zeller M.
        • Steg P.G.
        • Ravisy J.
        • Lorgis L.
        • Laurent Y.
        • Sicard P.
        • Janin-Manificat L.
        • Beer J.C.
        • Makki H.
        • Lagrost A.C.
        • Rochette L.
        • Cottin Y.
        • RICO Survey Working Group
        Relation between body mass index, waist circumference, and death after acute myocardial infarction.
        Circulation. 2008; 118: 482-490
        • Thygesen K.
        • Alpert J.S.
        • Jaffe A.S.
        • Simoons M.L.
        • Chaitman B.R.
        • White H.D.
        • Katus H.A.
        • Lindahl B.
        • Morrow D.A.
        • Clemmensen P.M.
        • Johanson P.
        • Hod H.
        • Underwood R.
        • Bax J.J.
        • Bonow R.O.
        • Pinto F.
        • Gibbons R.J.
        • Fox K.A.
        • Atar D.
        • Newby L.K.
        • Galvani M.
        • Hamm C.W.
        • Uretsky B.F.
        • Steg P.G.
        • Wijns W.
        • Bassand J.P.
        • Menasché P.
        • Ravkilde J.
        • Ohman E.M.
        • Antman E.M.
        • Wallentin L.C.
        • Armstrong P.W.
        • Simoons M.L.
        • Januzzi J.L.
        • Nieminen M.S.
        • Gheorghiade M.
        • Filippatos G.
        • Luepker R.V.
        • Fortmann S.P.
        • Rosamond W.D.
        • Levy D.
        • Wood D.
        • Smith S.C.
        • Hu D.
        • Lopez-Sendon J.L.
        • Robertson R.M.
        • Weaver D.
        • Tendera M.
        • Bove A.A.
        • Parkhomenko A.N.
        • Vasilieva E.J.
        • Mendis S.
        • Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction
        Third universal definition of myocardial infarction.
        Circulation. 2012; 126: 2020-2035
        • Levey A.S.
        • Stevens L.A.
        • Schmid C.H.
        • Zhang Y.L.
        • Castro 3rd, A.F.
        • Feldman H.I.
        • Kusek J.W.
        • Eggers P.
        • Van Lente F.
        • Greene T.
        • Coresh J.
        • CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
        A new equation to estimate glomerular filtration rate.
        Ann Intern Med. 2009; 150: 604-612
        • Fliser D.
        • Laville M.
        • Covic A.
        • Fouque D.
        • Vanholder R.
        • Juillard L.
        • Van Biesen W.
        European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy.
        Nephrol Dial Transplant. 2012; 27: 4263-4272
        • McCullough P.A.
        Contrast-induced acute kidney injury.
        J Am Coll Cardiol. 2008; 51: 1419-1428
        • Weisbord S.D.
        • Palevsky P.M.
        Contrast-induced acute kidney injury: short- and long-term Implications.
        Semin Nephrol. 2011; 31: 300-309
        • Mehran R.
        • Aymong E.D.
        • Nikolsky E.
        • Lasic Z.
        • Iakovou I.
        • Fahy M.
        • Mintz G.S.
        • Lansky A.J.
        • Moses J.W.
        • Stone G.W.
        • Leon M.B.
        • Dangas G.
        A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.
        J Am Coll Cardiol. 2004; 44: 1393-1399
        • Tsai T.T.
        • Patel U.D.
        • Chang T.I.
        • Kennedy K.F.
        • Masoudi F.A.
        • Matheny M.E.
        • Kosiborod M.
        • Amin A.P.
        • Messenger J.C.
        • Rumsfeld J.S.
        • Spertus J.A.
        Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.
        JACC Cardiovasc Interv. 2014; 7: 1-9
        • Rodrigues F.B.
        • Bruetto R.G.
        • Torres U.S.
        • Otaviano A.P.
        • Zanetta D.M.
        • Burdmann E.A.
        Incidence and mortality of acute kidney injury after myocardial infarction: a comparison between KDIGO and RIFLE criteria.
        PLoS One. 2013; 8: e69998
        • Patel U.D.
        • Garg A.X.
        • Krumholz H.M.
        • Shlipak M.G.
        • Coca S.G.
        • Sint K.
        Preoperative serum brain natriuretic peptide and risk of acute kidney injury after cardiac surgery.
        Circulation. 2012; 125: 1347-1355
        • Lorgis L.
        • Zeller M.
        • Dentan G.
        • Sicard P.
        • Buffet P.
        • L'Huillier I.
        • Beer J.C.
        • Vincent-Martin M.
        • Makki H.
        • Gambert P.
        • Cottin Y.
        • RICO Survey Working Group
        Prognostic value of N-terminal pro-brain natriuretic peptide in elderly people with acute myocardial infarction: prospective observational study.
        BMJ. 2009; 338: 1605-1623
        • Sakai H.
        • Tsutamoto T.
        • Ishikawa C.
        • Tanaka T.
        • Fujii M.
        • Yamamoto T.
        • Takashima H.
        • Horie M.
        Direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP secretion and extent of coronary artery stenosis in patients with stable coronary artery disease.
        Circ J. 2007; 71: 499-505
        • Tsutamoto T.
        • Sakai H.
        • Ishikawa C.
        • Fujii M.
        • Tanaka T.
        • Yamamoto T.
        • Takashima H.
        • Ohnishi M.
        • Wada A.
        • Horie M.
        Direct comparison of transcardiac difference between brain natriuretic peptide (BNP) and N-terminal pro-BNP in patients with chronic heart failure.
        Eur J Heart Fail. 2007; 9: 667-673
        • Vickery S.
        • Price C.P.
        • John R.I.
        • Abbas N.A.
        • Webb M.C.
        • Kempson M.E.
        • Lamb E.J.
        B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy.
        Am J Kidney Dis. 2005; 46: 610-620
        • Yasue H.
        • Yoshimura M.
        • Sumida H.
        • Kikuta K.
        • Kugiyama K.
        • Jougasaki M.
        • Ogawa H.
        • Okumura K.
        • Mukoyama M.
        • Nakao K.
        Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
        Circulation. 1994; 90: 195-203
        • Chan N.Y.
        • Seyedi N.
        • Takano K.
        • Levi R.
        An unsuspected property of natriuretic peptides: promotion of calcium-dependent catecholamine release via protein kinase G-mediated phosphodiesterase type 3 inhibition.
        Circulation. 2012; 125: 298-307
        • Toader E.
        • McAllen R.M.
        • Cividjian A.
        • Woods R.L.
        • Quintin L.
        Effect of systemic B-type natriuretic peptide on cardiac vagal motoneuron activity.
        Am J Physiol Heart Circ Physiol. 2007; 293: H3465-H3470
        • Lorgis L.
        • Moreau D.
        • Mock L.
        • Daumas B.
        • Potard D.
        • Touzery C.
        • Cottin Y.
        • Zeller M.
        High N-terminal pro-B-type natriuretic peptide levels are associated with reduced heart rate variability in acute myocardial infarction.
        PLoS One. 2012; 7: e44677
        • André R.
        • Elbaz M.
        • Simon T.
        • Khalife K.
        • Lim P.
        • Ennezat P.V.
        • Coste P.
        • Le Breton H.
        • Bataille V.
        • Ferrières J.
        • Danchin N.
        Prevalence, clinical profile and 3-year survival of acute myocardial infarction patients with and without obstructive coronary lesions: the FAST-MI 2005 registry.
        Int J Cardiol. 2014; 172: 247-249